Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Acacia Mining PLC stock logo
ABGLF
Acacia Mining
$3.09
$3.09
$1.99
$3.09
$1.27BN/A32,275 shsN/A
Clinigen Group plc stock logo
CLIGF
Clinigen Group
$8.02
$8.02
$8.02
$11.56
$1.07B0.498,620 shsN/A
FIH Mobile Limited stock logo
FXCNY
FIH Mobile
$13.25
$8.40
$1.50
$2.67
$5.22BN/A968 shsN/A
Petrofac Ltd. stock logo
POFCY
Petrofac
$0.12
$0.12
$0.02
$3.27
$121.75M2.77N/AN/A
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
$57.56
-3.4%
$64.15
$54.95
$141.74
$4.09B0.68932 shs165 shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Acacia Mining PLC stock logo
ABGLF
Acacia Mining
0.00%0.00%0.00%0.00%0.00%
Clinigen Group plc stock logo
CLIGF
Clinigen Group
0.00%0.00%0.00%0.00%0.00%
FIH Mobile Limited stock logo
FXCNY
FIH Mobile
-0.53%+12.29%+12.29%+728.13%+562.50%
Petrofac Ltd. stock logo
POFCY
Petrofac
0.00%0.00%0.00%+230.75%+42.89%
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
0.00%+3.13%-21.40%-4.70%-57.46%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Acacia Mining PLC stock logo
ABGLF
Acacia Mining
N/AN/AN/AN/AN/AN/AN/AN/A
Clinigen Group plc stock logo
CLIGF
Clinigen Group
N/AN/AN/AN/AN/AN/AN/AN/A
FIH Mobile Limited stock logo
FXCNY
FIH Mobile
N/AN/AN/AN/AN/AN/AN/AN/A
Petrofac Ltd. stock logo
POFCY
Petrofac
N/AN/AN/AN/AN/AN/AN/AN/A
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Acacia Mining PLC stock logo
ABGLF
Acacia Mining
0.00
N/AN/AN/A
Clinigen Group plc stock logo
CLIGF
Clinigen Group
0.00
N/AN/AN/A
FIH Mobile Limited stock logo
FXCNY
FIH Mobile
0.00
N/AN/AN/A
Petrofac Ltd. stock logo
POFCY
Petrofac
0.00
N/AN/AN/A
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
3.80
Strong BuyN/AN/A

Current Analyst Ratings Breakdown

Latest CLIGF, ZLDPF, POFCY, ABGLF, and FXCNY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/7/2025
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
7/1/2025
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
(Data available from 7/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Acacia Mining PLC stock logo
ABGLF
Acacia Mining
N/AN/AN/AN/AN/AN/A
Clinigen Group plc stock logo
CLIGF
Clinigen Group
$704.71M1.51$1.43 per share5.60$4.52 per share1.77
FIH Mobile Limited stock logo
FXCNY
FIH Mobile
$6.45B0.81$0.42 per share31.43$3.96 per share3.35
Petrofac Ltd. stock logo
POFCY
Petrofac
$2.50B0.05N/AN/A($0.42) per share-0.27
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
$9.09M449.74N/AN/A$17.59 per share3.27
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Acacia Mining PLC stock logo
ABGLF
Acacia Mining
N/AN/A0.00N/AN/AN/AN/AN/A
Clinigen Group plc stock logo
CLIGF
Clinigen Group
$40.78MN/A0.00N/AN/AN/AN/AN/A
FIH Mobile Limited stock logo
FXCNY
FIH Mobile
-$120.68MN/A0.00N/AN/AN/AN/A8/7/2025 (Estimated)
Petrofac Ltd. stock logo
POFCY
Petrofac
-$505MN/A0.002.88N/AN/AN/AN/AN/A
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
-$156.43M-$2.49N/AN/AN/A-2,127.09%-13.40%-12.28%8/13/2025 (Estimated)

Latest CLIGF, ZLDPF, POFCY, ABGLF, and FXCNY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
-$0.77-$0.67+$0.10-$0.67$248.61 million$1.14 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Acacia Mining PLC stock logo
ABGLF
Acacia Mining
N/AN/AN/AN/AN/A
Clinigen Group plc stock logo
CLIGF
Clinigen Group
N/AN/AN/AN/AN/A
FIH Mobile Limited stock logo
FXCNY
FIH Mobile
$0.060.48%N/AN/AN/A
Petrofac Ltd. stock logo
POFCY
Petrofac
N/AN/AN/AN/AN/A
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Acacia Mining PLC stock logo
ABGLF
Acacia Mining
N/AN/AN/A
Clinigen Group plc stock logo
CLIGF
Clinigen Group
N/AN/AN/A
FIH Mobile Limited stock logo
FXCNY
FIH Mobile
N/A
1.22
0.83
Petrofac Ltd. stock logo
POFCY
Petrofac
N/AN/AN/A
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
0.03
25.10
25.07

Institutional Ownership

CompanyInstitutional Ownership
Acacia Mining PLC stock logo
ABGLF
Acacia Mining
N/A
Clinigen Group plc stock logo
CLIGF
Clinigen Group
N/A
FIH Mobile Limited stock logo
FXCNY
FIH Mobile
N/A
Petrofac Ltd. stock logo
POFCY
Petrofac
N/A
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Acacia Mining PLC stock logo
ABGLF
Acacia Mining
1,331410.09 millionN/ANot Optionable
Clinigen Group plc stock logo
CLIGF
Clinigen Group
1,069133.03 millionN/ANot Optionable
FIH Mobile Limited stock logo
FXCNY
FIH Mobile
6,657394.12 millionN/ANot Optionable
Petrofac Ltd. stock logo
POFCY
Petrofac
8,1911.06 billionN/ANot Optionable
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
34071.02 millionN/ANot Optionable

Recent News About These Companies

Financial Review: Zealand Pharma A/S (ZLDPF) & Its Competitors
Zealand Pharma appoints Utpal Singh as CSO

New MarketBeat Followers Over Time

Media Sentiment Over Time

Acacia Mining stock logo

Acacia Mining OTCMKTS:ABGLF

$3.09 0.00 (0.00%)
As of 05/12/2021

Acacia Mining plc, together with its subsidiaries, mines, processes, and sells gold in Africa. The company has three gold mines in north-west Tanzania, including Bulyanhulu, Buzwagi, and North Mara; and a portfolio of exploration projects at various stages of development in Tanzania, Kenya, Burkina Faso, and Mali. It also produces co-products, such as copper and silver. The company was formerly known as African Barrick Gold plc and changed its name to Acacia Mining plc in November 2014. The company was incorporated in 2010 and is headquartered in London, the United Kingdom. Acacia Mining plc is a subsidiary of Barrick Gold Corporation.

Clinigen Group stock logo

Clinigen Group OTCMKTS:CLIGF

$8.02 0.00 (0.00%)
As of 03/24/2023

Clinigen Group plc operates as a pharmaceutical and services company in the United Kingdom, rest of Europe, the United States, South Africa, Australia, and internationally. It operates through Services and Products divisions. The company provides a set of niche and high value services to pharma and biotech clients prior to product launch. It also provides access to critical medicines around the world for patients with unmet needs. In addition, the company provides a portfolio of specialist medicines to service the needs of healthcare professionals and their patients in both licensed and unlicensed markets. Further, it offers Nortriptyline Colonis for the treatment of depressive disorder; Metformin Colonis for the treatment of type 2 diabetes mellitus; Magnesium Chewable Tablets, an oral magnesium supplements for the treatment of patients with chronic magnesium loss; Iloprost, a concentrate for solution for infusion; Glycopyrronium Bromide, an oral solution for the treatment of severe sialorrhoea; Acetylcysteine, an oral solution for the treatment of respiratory disorders associated with thick, viscous, and mucus hypersecretion; Cardioxane that protects the heart against the cardiotoxic effects of anthracyclines; Ethyol, which protect against the harmful effects of chemotherapy medications and radiation treatment; Proleukin for the treatment of kidney cancer; Imukin that is used in chronic granulomatous disease; Totect, a dexrazoxane product; Foscavir, an anti-virals that work by stopping viruses from multiplying in number; and Savene, which is indicated in adults for the treatment of anthracycline extravasation. The company was incorporated in 2008 and is headquartered in Burton-on-Trent, the United Kingdom.

FIH Mobile stock logo

FIH Mobile OTCMKTS:FXCNY

$13.25 0.00 (0.00%)
As of 07/10/2025

FIH Mobile Limited, an investment holding company, provides integrated manufacturing services for the handset industry worldwide. The company designs, manufactures, and trades in handsets, as well as offers repair services. It is also involved in the research and development activity; manufacture and sale of electronic products; and import and export activities. The company was formerly known as Foxconn International Holdings Limited and changed its name to FIH Mobile Limited in May 2013. FIH Mobile Limited was incorporated in 2000 and is headquartered in New Taipei City, Taiwan. FIH Mobile Limited is a subsidiary of Foxconn (Far East) Limited.

Petrofac stock logo

Petrofac OTCMKTS:POFCY

$0.12 0.00 (0.00%)
As of 07/10/2025

Petrofac Limited designs, builds, manages, and maintains infrastructure for the energy industries in the United Kingdom, Algeria, Thailand, Oman, Kuwait, Iraq, the United Arab Emirates, the Netherlands, and internationally. It operates through three segments: Engineering & Construction (E&C); Asset Solutions; and Integrated Energy Services (IES). The E&C segment provides onshore and offshore engineering, procurement, construction, installation, and commissioning services. The Asset Solutions segment offers concept, feasibility, and front-end engineering design services, as well as manages and maintains onshore and offshore operations. The IES segment focuses on delivering value from the existing asset portfolio. The company was founded in 1981 and is based in St Helier, Jersey.

Zealand Pharma A/S stock logo

Zealand Pharma A/S OTCMKTS:ZLDPF

$57.56 -2.00 (-3.36%)
As of 10:59 AM Eastern

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company offers Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon that is in Phase III clinical trials for treating congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.